I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Home > News and Publications > JHM Publications > Promise and Progress > Promise & Progress - A Spectrum of Achievements
Promise and Progress - Tiny "Ship" Delivers Death Command to Brain Cancer
Promise & Progress - A Spectrum of Achievements
Tiny "Ship" Delivers Death Command to Brain Cancer
Date: January 15, 2015
ACS Nano, April 26 and March 27, 2014.
Researchers used tiny biodegradable nanoparticles to deliver “death genes” to human brain cancer cells implanted in mice. Johns Hopkins biomedical engineers collaborated with neurosurgeons to use the nanoparticles to transport and turn on a test gene in the animal model. The team says the results are proof-of-principle that one day such particles could be loaded with a gene and given to brain cancer patients during neurosurgery to selectively kill off any remaining tumor cells without harming normal brain tissue.
“This is evidence that these tiny Trojan horses can carry genes that selectively induce death in cancer cells, while leaving healthy cells healthy,” says Jordan Green, Ph.D., associate professor of biomedical engineering.
Green worked with neurosurgeon Alfredo Quinones-Hinojosa, M.D., and used glioblastoma brain cancer cells donated by Quinones-Hinojosa’s patients to develop the nanoparticle vehicle that is able to deliver tumor-destroying DNA instructions directly to cancer cells. Green specializes in producing the tiny, round biodegradable plastic particles and tested dozens of variations to find the best one for transporting the gene instructions.
For the test voyage of the nanoparticle, the cargo was a gene that causes cells to glow red or green. Although the nanoparticles entered healthy cells and cancer cells in similar numbers, healthy cells rarely produced the glowing protein. “This is exactly what we wanted to see—cancer specificity,” says Green, “but we are still researching the mechanism that allows this to occur.”
In a related animal study, Green used a different particle to effectively carry and deliver another cancer fighting cargo. This particle delivered siRNAs—interfering molecules that can turn cancer genes off.
Brain cancers are among the most lethal types of cancer with few curative treatment options. “It is exciting that we have a found a way to safely and selectively target genetic instructions to cancer cells,” says Quinones.
The research was funded by the National Institute of Biomedical Imaging and Bioengineering (1R01 EB016721), the National Cancer Institute (R21 CA152473, R25 CA153952), and the Maryland Stem Cell Research Fund-TEDCO.
Articles in this Issue
- World's First Protein Catalog
- How Cancer Cells Keep Going When Other Cells Stop
- Mega Analysis Uncovers Prostate Cancer Risk
- Tobacco and Oral Cancer-Causing Infection
- Test for Oral Cancers
- Shortened BMT Treatment Gets the Job Done
- Greenberg Bladder Cancer Institute Awards First Research Grant
- No More Repeat Prostate Biopsies
- How Breast Cancer Spreads
- Tiny "Ship" Delivers Death Command to Brain Cancer
- Human Chemical Detoxifiers
- Cancer-Fighting Bacteria
- Game Theory and Cancer
- Recruiting Cancer Immunity
- Broccoli Sprouts Detoxify Dirty Air
- Personalized Prostate Cancer Approach
- Amen to Miracles